SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Natco Pharma

Natco Pharma

BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01018 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Nov 28, 16:15
1359.00
-31.30 (-2.25%)
VOLUME 5,067
AVERAGE VOLUME
5-Day 6,455
10-Day 4,309
30-Day 4,983
VOLUME SHOCKER
5-Day 6,455
10-Day 4,309
30-Day 4,983
Prev. Close
1390.30
Open Price
1401.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 1350.10 1401.00
52 Wk Low/High 655.55 1585.70
LIVE
NSE
Nov 28, 16:15
1363.10
-29.95 (-2.15%)
VOLUME 23,092
AVERAGE VOLUME
5-Day 58,063
10-Day 39,843
30-Day 42,018
VOLUME SHOCKER
5-Day 58,063
10-Day 39,843
30-Day 42,018
Prev. Close
1393.05
Open Price
1399.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
1363.10 (166)
Today’s Low/High 1355.10 1399.00
52 Wk Low/High 650.00 1590.00
Action in Natco Pharma

No recommendations so far.

What's your call on Natco Pharma today?
Read 12 investor views

MARKET CAP (Rs Cr)
4,561.61
*P/E
35.10
*BOOK VALUE (Rs)
218.49
DIV (%)
50.00%
Market Lot
1
INDUSTRY P/E
24.73
*EPS (TTM)
38.72
*P/C
29.10
*PRICE/BOOK
6.22
DIV YIELD.(%)
0.37%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
58.13 new
DELIVERY AVERAGES
3-Day 49.70%
5-Day 64.31%
8-Day 66.54%
* Based on standalone numbers
Track Natco Pharma on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

28 November 2014

buy

PNB Nov Fut

Entry Price (Rs)

1,036.00

Exit Price (Rs)

1,058.00

Gain (Rs)

22.00

buy

PNB Nov Fut

Entry Price (Rs)

1,027.00

Exit Price (Rs)

1,048.00

Gain (Rs)

21.00

buy

MCX Nov Fut

Entry Price (Rs)

860.00

Exit Price (Rs)

879.00

Gain (Rs)

19.00

buy

HDFC Nov Fut

Entry Price (Rs)

1,167.00

Exit Price (Rs)

1,183.00

Gain (Rs)

16.00

buy

Reliance Nov Fut

Entry Price (Rs)

1,008.00

Exit Price (Rs)

1,019.00

Gain (Rs)

11.00

buy

HavellsIndia Nov Fut

Entry Price (Rs)

313.75

Exit Price (Rs)

320.50

Gain (Rs)

7.00

buy

MothersonSumi Nov Fut

Entry Price (Rs)

425.50

Exit Price (Rs)

433.00

Gain (Rs)

7.00

buy

DaburIndia Nov Fut

Entry Price (Rs)

243.35

Exit Price (Rs)

248.50

Gain (Rs)

6.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 781.70 1401.00  
High Price 787.05 1401.00  
Low Price 773.00 1350.10  
Last Price 779.40 1359.00 74.36
Volume 4,985 5,067 1.64
Simple Moving Averages
Days BSE NSE
30 1379.58 1379.49
50 1416.68 1416.29
150 1127.48 1127.93
200 1041.78 1042.17

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Natco Pharma

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Consolidated (Sep '14)
(Jun '14)
Net Sales 209.06 190.48
Other Income 3.19 1.52
PBDIT 62.04 58.69
Net Profit 31.24 32.21

Annual Report

Download in PDF format 2014 |2013 |2012 |2011 |2010
Balance Sheet
(Jun '14)
(In Rs Cr)
Total Share Capital 33.07
Net Worth 732.90
Total Debt 193.60
Net Block 528.98
Investments 88.90
Net Current Assets 215.70
Total Assets 926.52
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 839.55 -0.29 932.00 552.50 173,884.57
Lupin 1481.10 2.22 1500.00 868.00 66,517.35
Dr Reddys Labs 3602.15 -0.16 3635.00 2250.00 61,368.33
Cipla 634.95 -0.21 671.95 366.70 50,981.49
Aurobindo Pharm 1092.80 0.90 1151.70 296.65 31,851.26
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Sep' 14Jun' 14Mar' 14Dec' 13
Promoter53.5253.5253.5453.70
FII16.6314.5313.0011.46
DII7.848.779.7210.83
Others22.0123.1823.7424.01
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Natco House, Road No.2,,Banjara Hills
City
Hyderabad
State
Telangana
Pin Code
500033
Tel. No.
040-23547532
Fax No.
040-23548243
REGISTRARS
Name
Venture Capital & Corporate Investments Pvt. Ltd.
Address
No. 12-10-167, Bharat Nagar
City
Hyderabad - 500018
State
Telangana
Tel. No.
040-23818475, 23818476, 23868023
Fax No.
040-23868024
MANAGEMENT
Name
Designation
V C Nannapaneni
Chairman & Managing Director
Rajeev Nannapaneni
Vice Chairman & CEO
P Bhaskara Narayana
Director & CFO
A K S Bhujanga Rao
President & Director
T V Rao
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

DCB Bank Recommended on Aug 19th 2014

Recommended price 81.00  |  Peak from reco 107.05 31.51%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Natco Pharma

Natco Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 4,561.61 crore.The company has reported a consolidated sales of Rs 209.06 crore and a Net Profit of Rs 31.24 crore for the quarter ended Sep 2014.

The company management includes V C Nannapaneni - Chairman & Managing Director, Rajeev Nannapaneni - Vice Chairman & CEO, P Bhaskara Narayana - Director & CFO, A K S Bhujanga Rao - President & Director, T V Rao - Director, G S Murthy - Director, B S Bajaj - Director, D G Prasad - Director, Vivek Chhachhi - Director, Tarun Khanna - Alternate Director, Leela Digumarti - Additional Director, P S R K Prasad - Additional Director.

It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.

Its Registered office is at Natco House, Road No.2,,Banjara Hills Hyderabad,Telangana - 500033.

Their Registrars are Venture Capital & Corporate Investments Pvt. Ltd.

Quick Links for Natco Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Natco Pharma